Mesenchymal stem cells: Biology, and perspectives of clinical use;Mezenchymalne komórki macierzyste: Ich biologia i perspektywy zastosowań klinicznych

Acta Haematologica Polonica

Volumn 36, Issue 2, 2005, Pages 161-166

  Urbaniak Kujda, Donata ^a   Wołowiec, Dariusz ^a   Tomaszewska Toporska, Beata ^a   Kapelko Słowik, Katarzyna ^a   Kuliczkowski, Kazimierz ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Mesenchymal stem cells

Indexed keywords

5' NUCLEOTIDASE; ACTIVATED LEUKOCYTE CELL ADHESION MOLECULE; ANTIGEN; CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CYTOKINE; ENDOGLIN; HERMES ANTIGEN; MEMBRANE ANTIGEN; STEM CELL FACTOR RECEPTOR; THY 1 ANTIGEN; UNCLASSIFIED DRUG;

ADIPOCYTE; ANTIGEN PRESENTING CELL; BONE MARROW; CARTILAGE CELL; CELL DIFFERENTIATION; CELL POPULATION; CYTOLOGY; FIBROBLAST; GRAFT VERSUS HOST REACTION; HEART INFARCTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MESENCHYMAL STEM CELL; MUSCLE CELL; ORTHOPEDIC SURGERY; OSTEOBLAST; OSTEOPOROSIS; PLASTIC SURGERY; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 27144437894     PISSN: 00015814     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Devine SM, Hoffman R. Role of mesenchymal stem cells in hematopoietic stem cell transplantation. Curr Opin Hematol 2000; 7: 358-363.
2. Minguell JJ, Erices A, Conget P. Mesenchymal stem cells. Exp Biol Med. 2001; 226: 507-520.
3. Tocci A., Forte L. Mesenchymal stem cell: use and perspectives. Hematol J. 2003; 4: 92-96.
4. Mbalaviele G, Jaiswal N, Meng A, Cheng L, Van den Bos Ch, Thiede M. Human mesenchymal stem cells promote human osteoclast differentiation from CD34+ bone marrow hematopoietic progenitors. Endocrinology 1999; 140: 3736-3743.
5. Jlang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002; 418: 41-49.
6. Fakuda K. Development of regenerative cardiomyocytes from mesenchymal stem cells for cardiovascular tissue engineering. Artif Organs 2001; 25: 187-193.
7. Fibbe WE, Noort WA. Mesenchymal stem cells and hematopoietic stem cell transplantation. Ann NY Acad Sci 2003; 996: 235-244.
8. Javazon EH, Beggs KJ, Flake AW. Mesenchymal stem cells: paradoxes of passaging. Exp Hematol 2004; 32: 414-425.
9. Conget PA, Minguell JJ. Phenotypical and functional properties of human bone marrow mesenchymal progenitor cells. J Cell Physiol 1999; 181: 67-73.
10. Mosca JD, Hendricks JK, Buyaner D, Davis-Sproul J et al. Mesenchymal stem cells as vehicles for gene delivery. Clin Orthop, and Res 2000; 379: 71-90.
11. Chuah MK, Van Damme A, Zwinnen H, Goovaerts I, Vanslembrouck V, Collen D, et al. Long-term persistence of human bone marrow stromal cells transduced with factor VIII- retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Human Gene Ther 2000; 11: 729-738.
12. Keating A, Berkahn L, Filshie R. A phase I study of the transplantation of genetically marked autologous bone marrow stromal cells. Human Gene Ther 1998; 9: 591-600.
13. Maitra B, Szekely E, Gjini K, Laughlin MJ, Dennis J, Haynesworth SE, Koȩ ON. Human mesenchymal stem cells support unrelated donor hematopoietic stem cells and suppress T-cell activation. Bone Marrow Transplant 2004; 1-8.
14. Hofstetter CP, Schwarz EJ, Hess D et al. Marrow stromal cells form guiding strands in the injured spinal cord and promote recovery. Proc Natl Acad Sci USA 2002; 99: 2199-2204.
15. Lu D, Li Y, Wang L, Chen J, Mahmood A, Chopp M. Intraarterial administration of marrow stromal cells in a rat model of traumatic brain injury. J Neurotrauma 2001; 18: 813-819.